- Stocks
- Healthcare
- NASDAQ: AXNX

Price (delayed)

$59.74

Market cap

$2.5B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.63

Enterprise value

$2.46B

AXNX's equity has surged by 91% year-on-year and by 15% since the previous quarter

The revenue has increased by 7% since the previous quarter

AXNX's EPS is up by 41% year-on-year but it is down by 10% since the previous quarter

AXNX's quick ratio is down by 30% year-on-year but it is up by 12% since the previous quarter

The company's debt has surged by 177% YoY and by 171% QoQ

What are the main financial stats of AXNX

Market
Valuations
Earnings

Shares outstanding

41.9M

Market cap

$2.5B

Enterprise value

$2.46B

Price to earnings (P/E)

N/A

Price to book (P/B)

7.51

Price to sales (P/S)

19.79

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

20.55

Revenue

$119.61M

EBIT

-$60.59M

EBITDA

-$58.09M

Free cash flow

-$88.37M

Per share
Balance sheet
Liquidity

EPS

-$1.63

Free cash flow per share

-$2.23

Book value per share

$7.95

Revenue per share

$3.02

TBVPS

$6.12

Total assets

$444.97M

Total liabilities

$114.82M

Debt

$85.4M

Equity

$330.15M

Working capital

$204.33M

Debt to equity

0.26

Current ratio

9.5

Quick ratio

6.34

Net debt/EBITDA

0.78

Margins
Efficiency
Dividend

EBITDA margin

-48.6%

Gross margin

59.4%

Net margin

-52.5%

Operating margin

-50.7%

Return on assets

-16.9%

Return on equity

-20.8%

Return on invested capital

-62%

Return on capital employed

-14.4%

Return on sales

-50.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Axonics Modulation Technologies stock price performed over time

Intraday

2.51%

1 week

0.23%

1 month

10.57%

1 year

50.63%

YTD

19.67%

QTD

-0.25%

How have Axonics Modulation Technologies's revenue and profit performed over time

Revenue

$119.61M

Gross profit

$71.09M

Operating income

-$60.67M

Net income

-$62.8M

Gross margin

59.4%

Net margin

-52.5%

The operating margin has surged by 76% year-on-year but it has declined by 5% since the previous quarter

The company's net margin has surged by 75% YoY but it fell by 7% QoQ

The company's operating income rose by 26% YoY but it fell by 13% QoQ

The net income has grown by 23% YoY but it has contracted by 14% from the previous quarter

What is Axonics Modulation Technologies's growth rate over time

What is Axonics Modulation Technologies stock price valuation

P/E

N/A

P/B

7.51

P/S

19.79

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

20.55

AXNX's EPS is up by 41% year-on-year but it is down by 10% since the previous quarter

AXNX's equity has surged by 91% year-on-year and by 15% since the previous quarter

The P/B is 19% above the last 4 quarters average of 6.3

The revenue has increased by 7% since the previous quarter

The price to sales (P/S) is 5% lower than the last 4 quarters average of 20.9

How efficient is Axonics Modulation Technologies business performance

AXNX's ROS has soared by 75% year-on-year but it is down by 7% since the previous quarter

The ROE has soared by 64% YoY

AXNX's ROA has soared by 63% YoY and by 3.4% from the previous quarter

AXNX's ROIC is up by 48% YoY and by 16% QoQ

What is AXNX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for AXNX.

How did Axonics Modulation Technologies financials performed over time

The total liabilities has surged by 156% year-on-year and by 109% since the previous quarter

The total assets has soared by 105% YoY and by 30% from the previous quarter

The company's debt is 74% lower than its equity

The company's debt has surged by 177% YoY and by 171% QoQ

AXNX's debt to equity has soared by 136% since the previous quarter and by 44% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.